Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1970-1976

  Roda, Julie M ^a   Sumner, Laura A ^a   Evans, Randall ^a   Phillips, Gary S ^a   Marsh, Clay B ^a   Eubank, Timothy D ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LYSINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL PARAMETERS; CANCER INHIBITION; CONTROLLED STUDY; LUNG METASTASIS; MACROPHAGE; MELANOMA; MICROMETASTASIS; MICROVESSEL DENSITY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MACROPHAGES; MELANOMA; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; OXYGEN CONSUMPTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 80051946936     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100841     Document Type: Article

References (28)

1. Steele, R. J., M. Brown, and O. Eremin. 1985. Characterisation of macrophages infiltrating human mammary carcinomas. Br. J. Cancer 51: 135-138. (Pubitemid 15151700)
2. Lissbrant, I. F., P. Stattin, P. Wikstrom, J. E. Damber, L. Egevad, and A. Bergh. 2000. Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int. J. Oncol. 17: 445-451.
3. Bingle, L., N. J. Brown, and C. E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 196: 254-265. (Pubitemid 34189413)
4. Leek, R. D., N. C. Hunt, R. J. Landers, C. E. Lewis, J. A. Royds, and A. L. Harris. 2000. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190: 430-436. (Pubitemid 30163582)
5. Lewis, J. S., R. J. Landers, J. C. Underwood, A. L. Harris, and C. E. Lewis. 2000. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 192: 150-158.
6. Manalo, D. J., A. Rowan, T. Lavoie, L. Natarajan, B. D. Kelly, S. Q. Ye, J. G. Garcia, and G. L. Semenza. 2005. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669. (Pubitemid 40070750)
7. Eubank, T. D., R. Roberts, M. Galloway, Y. Wang, D. E. Cohn, and C. B. Marsh. 2004. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 21: 831-842. (Pubitemid 39626673)
8. Kendall, R. L., and K. A. Thomas. 1993. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90: 10705-10709. (Pubitemid 23347111)
9. Kendall, R. L., G. Wang, and K. A. Thomas. 1996. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226: 324-328. (Pubitemid 26331903)
10. Eubank, T. D., J. M. Roda, H. Liu, T. O'Neil, and C. B. Marsh. 2010. Opposing roles for HIF-1{alpha} and HIF-2{alpha} in the regulation of angiogenesis by mononuclear phagocytes. Blood 117: 323-332.
11. Leek, R. D., K. L. Talks, F. Pezzella, H. Turley, L. Campo, N. S. Brown, R. Bicknell, M. Taylor, K. C. Gatter, and A. L. Harris. 2002. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res. 62: 1326-1329. (Pubitemid 34407787)
12. Talks, K. L., H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, and A. L. Harris. 2000. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumorassociated macrophages. Am. J. Pathol. 157: 411-421. (Pubitemid 30626905)
13. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Förster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657. (Pubitemid 36331777)
14. Skuli, N., L. Liu, A. Runge, T. Wang, L. Yuan, S. Patel, L. Iruela-Arispe, M. C. Simon, and B. Keith. 2009. Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 114: 469-477.
15. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277. (Pubitemid 29523965)
16. Tsukamoto, K., S. Hirata, A. Osada, R. Kitamura, and S. Shimada. 2000. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model. Pigment Cell Res. 13: 185-189. (Pubitemid 30400285)
17. Eubank, T. D., R. D. Roberts, M. Khan, J. M. Curry, G. J. Nuovo, P. Kuppusamy, and C. B. Marsh. 2009. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res. 69: 2133-2140.
18. Locke, F., J. I. Clark, and T. F. Gajewski. 2010. A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma. Cancer Chemother. Pharmacol. 65: 509-514.
19. Ravaud, A., M. Delaunay, C. Chevreau, V. Coulon, M. Debled, C. Bret-Dibat, F. Courbon, N. Gualde, and B. Nguyen Bui. 2001. Granulocyte- macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: A randomized phase II trial. Br. J. Cancer 85: 1467-1471. (Pubitemid 34001575)
20. Shi, L., D. Lei, C. Ma, F. Xu, Y. Li, Y. Wang, N. Cong, D. Liu, and X. L. Pan. 2010. Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma. J. Int. Med. Res. 38: 1276-1286.
21. Ly, L. V., A. Baghat, M. Versluis, E. S. Jordanova, G. P. Luyten, N. Van Rooijen, T. Van Hall, P. A. Van der Velden, and M. J. Jager. 2010. In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J. Immunol. 185: 3481-3488.
22. Ascierto, P. A., E. Leonardi, A. Ottaiano, M. Napolitano, S. Scala, and G. Castello. 2004. Prognostic value of serum VEGF in melanoma patients: A pilot study. Anticancer Res. 24: 4255-4258. (Pubitemid 40468737)
23. Semenza, G. L. 2007. Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling. J. Cell. Biochem. 102: 840-847. (Pubitemid 350036924)
24. Mazzone, M., D. Dettori, R. Leite de Oliveira, S. Loges, T. Schmidt, B. Jonckx, Y. M. Tian, A. A. Lanahan, P. Pollard, C. Ruiz de Almodovar, et al. 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
25. Hiraoka, K., M. Zenmyo, K. Watari, H. Iguchi, A. Fotovati, Y. N. Kimura, F. Hosoi, T. Shoda, K. Nagata, H. Osada, et al. 2008. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/ macrophages. Cancer Sci. 99: 1595-1602.
26. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193: 727-740.
27. Imtiyaz, H. Z., E. P. Williams, M. M. Hickey, S. A. Patel, A. C. Durham, L. J. Yuan, R. Hammond, P. A. Gimotty, B. Keith, and M. C. Simon. 2010. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest. 120: 2699-2714.
28. Owen, J. L., M. Torroella-Kouri, M. E. Handel-Fernandez, and V. Iragavarapu- Charyulu. 2007. GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice. Int. J. Mol. Med. 20: 129-136.